NPLATE 250 micrograms, powder and solvent for solution for injection bottle, 0.72 ml
Active ingredients: Romiplostim
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 0.72 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NPLATE 250 microgrammes, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 0,72 ml avec piston(s) avec adaptateur(s) pour flacon avec seringue(s) avec aiguille(s) avec tampon(s) alcoolisé(s)
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Oct 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64313253CIP73598558CIP133400935985583Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROMIPLOSTIMpoudre | 250 microgrammes · 0,5 ml de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.